PLSE - Pulse Biosciences, Inc.
NEXT EARNINGS:
May 7, 2026
EPS Est: $-0.22
|
Rev Est: $400000
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$30.00
DETAILS
HIGH:
$30.00
LOW:
$30.00
MEDIAN:
$30.00
CONSENSUS:
$30.00
UPSIDE:
57.98%
Market Cap:
1.29B
Volume:
434,523
Avg Volume:
272,320
52 Week Range:
12.56-26.3
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
1.77
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
75
IPO Date:
2016-05-18
EPS (TTM):
-1.08
P/E Ratio:
-12.71
Revenue (TTM):
350,000
Total Assets:
94.54M
Total Debt:
7.53M
Cash & Equiv:
80.73M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-88.8%
Debt/Equity:
0.09
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-19 | $-0.26 | $-0.32 | +18.8% | $264000 | $400000 | -34.0% |
| 2025-11-05 | $-0.29 | $-0.31 | +6.5% | $86000 | $225000 | -61.8% |
| 2025-08-12 | $-0.28 | $-0.26 | -7.7% | — | $500000 | — |
| 2025-05-08 | $-0.17 | — | — | — | — | — |
| 2025-03-27 | $-0.17 | $-0.24 | +29.2% | $1.7M | — | — |
| 2024-10-30 | $-0.16 | $-0.24 | +33.3% | — | — | — |
| 2024-08-19 | $-0.20 | $-0.24 | +17.1% | — | — | — |
| 2024-05-07 | $-0.14 | $-0.24 | +41.7% | — | — | — |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 350,000 | 0 | 0 | 700,000 | 1.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (72.78M) | (53.59M) | (42.21M) | (58.51M) | (63.66M) | (49.74M) | (45.99M) | (37.55M) | (25.57M) | (9.52M) | (2.81M) | (474,857) |
| EPS | -1.08 | -0.92 | -0.88 | -1.72 | -2.28 | -2.14 | -2.22 | -2.20 | -1.73 | -0.86 | -0.37 | -0.19 |
| Total Assets | 94.54M | 132.46M | 59.15M | 77.88M | 54.25M | 41.29M | 41.91M | 70.64M | 49.82M | 26.31M | 14.33M | 17.90M |
| Total Debt | 7.53M | 8.90M | 9.14M | 75.96M | 11.25M | 11.36M | 6.72M | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 80.73M | 118.04M | 44.37M | 61.14M | 28.61M | 12.46M | 6.90M | 51.10M | 3.39M | 2.09M | 3.61M | 7.01M |
| Operating Cash Flow | (54.12M) | (36.34M) | (33.04M) | (47.01M) | (54.10M) | (35.37M) | (34.19M) | (23.90M) | (11.09M) | (8.05M) | (3.32M) | (173,143) |
| Free Cash Flow | (54.44M) | (36.47M) | (33.16M) | (47.41M) | (54.53M) | (35.81M) | (34.79M) | (24.17M) | (13.64M) | (8.12M) | (3.40M) | (252,000) |
| FCF per Share | -0.81 | -0.62 | -0.69 | -1.40 | -1.95 | -1.54 | -1.68 | -1.42 | -0.92 | -0.74 | -0.45 | -0.10 |
| Book Value | 80.66M | 114.86M | 44.36M | (2.25M) | 35.69M | 22.89M | 30.74M | 66.33M | 45.99M | 25.30M | 13.67M | 16.07M |
| Cash & ST Investments | 80.73M | 118.04M | 44.37M | 61.14M | 28.61M | 20.48M | 25.40M | 59.58M | 38.07M | 16.39M | 3.61M | 7.01M |
| ROC Equity | -0.90 | -0.47 | -0.95 | N/A | -1.78 | -2.17 | -1.50 | -0.57 | -0.56 | -0.38 | -0.21 | -0.03 |